High-Throughput CAR Library Screening for Rapid Candidate Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The current process for developing chimeric antigen receptors (CARs) is resource-intensive and labor-intensive, limiting the number of candidates that can be progressed, with a high risk of failure due to the mismatch between functional antibodies and CAR functionality, and a protracted approach that takes months to years, often resulting in only a few candidates being advanced for clinical evaluation.
Innovation Solution
A high-throughput method for screening CARs involves creating a library of CAR sequences with diverse recognition, hinge, transmembrane, and intracellular domains, expressed in cells, allowing for simultaneous evaluation of multiple CARs for desired functions such as affinity binding and signaling, using next-generation sequencing and machine learning to identify promising candidates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional manual methods are used to develop and test CARs, then the process allows for detailed characterization of each candidate, but the number of candidates that can be screened is limited to only 2-5 at a time, resulting in low success probability and prolonged development time
Solution Approach 1:
The patent segments the CAR development process into distinct modules: library construction phase (combining scFv with CAR backbone sequences), transduction phase (introducing CAR library into T cells), and screening phase (evaluating multiple CAR candidates simultaneously). This segmentation enables high-throughput processing while maintaining systematic control over each development stage.
Solution Approach 2:
The patent performs preliminary actions by pre-construction of comprehensive CAR libraries containing diverse scFv sequences combined with standardized CAR backbones before T cell transduction. This advance preparation of candidate pools allows simultaneous screening of many CAR variants, dramatically increasing productivity from 2-5 candidates to potentially hundreds or thousands of candidates evaluated in parallel.
2Loss of time
If traditional sequential methods are used for CAR development, then each candidate can be thoroughly characterized, but the development process takes many months to years and requires repeated iterations
Solution Approach 1:
The patent implements feedback mechanisms by screening multiple CAR candidates simultaneously and using the results to guide subsequent library construction and selection rounds. Performance data from functional assays, binding studies, and in vivo models feed back into optimizing the CAR library design, enabling rapid iterative improvement without the prolonged sequential timeline of traditional methods.
Solution Approach 2:
The patent applies parameter changes by systematically varying key CAR parameters including scFv affinity, hinge region length and composition, transmembrane domain characteristics, and intracellular signaling domain configurations. By exploring multiple parameter combinations in parallel through high-throughput screening, the method identifies optimal CAR configurations more rapidly than traditional single-candidate-at-a-time optimization.
3Ease of manufacture
If selection is based on monoclonal antibody criteria, then good antibody candidates are identified, but the functional performance of the resulting CARs may be poor due to mismatch between antibody and CAR functionality requirements
Solution Approach 1:
The patent inverts the traditional selection approach by prioritizing CAR functional performance over antibody characteristics. Instead of selecting scFvs based solely on their antibody performance metrics (affinity, specificity) and then testing CAR functionality, the method screens CAR candidates directly for functional performance including T cell activation, cytokine production, target cell killing, and in vivo efficacy. This inversion ensures that CAR functionality, not just antibody properties, drives candidate selection.
Solution Approach 2:
The patent employs a high-throughput screening approach that treats individual CAR candidates as disposable test units, rapidly evaluating many variants to identify successful candidates. This approach sacrifices the resource-intensive detailed characterization of each candidate in favor of screening large numbers of candidates with streamlined assays, thereby increasing the probability of identifying functionally superior CARs while reducing overall development time and cost.
Data Source
AI summary
A method for high-throughput screening of a chimeric antigen receptor (CAR) cell library is provided comprising the steps of (a) providing a recognition sequence library, a hinge region sequence library, a transmembrane sequence library and an intracellular domain sequence library; (b) preparing a CAR library; (c) preparing a CAR-cell library by introduction to, and expression of, the plurality of CAR sequences of the CAR library in one or more cells or a cell line; (d) screening the CAR-cell library in an assay; (e) evaluating the at least one function of each member of the CAR-cell library; (f) obtaining one or more sequences of one or more CARs expressed in the CAR-cell library and linking the obtained sequence(s) to the at least one function of the members of the CAR-cell library; g) identifying and selecting the or each sequence based on function. Methods of preparing the CAR library and a CAR-cell library and uses thereof are also provided.